10x Genomics, Inc. — Director's Dealing 2023

Jun 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2023-06-14

Reporting Person: Kosaraju Sridhar (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-14	Class A Common Stock	A	1865	—	Acquired	32443	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-14	Stock Option (right to buy)	$57.62	A	4661	Acquired	2033-06-14	Class A Common Stock (4661)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	3000	Indirect

Footnotes

F1: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.

F2: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.

F3: 1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date.